Skip to main content

Diagnostic Grifols, S.A.

Diagnostic Grifols, S.A.: 2 recalls listed since October 2026 across FDA; 2 ended.

By year

  • 20262

By agency

  • FDA2

By category

  • Drug2

All recalls (2)

Diagnostic Grifols Erytra Analyzer

The Erytra analyzer can assign incorrect results for an autocancelled and rescheduled test, potentially leading to an incident if a transfusion is performed.

Moderate risk, FDA, , Software defect

Diagnostic Grifols Erytra and Erytra Eflexis Automated Blood Grouping and Antibody Test Systems

The Erytra blood grouping system has an incorrect configuration that can cause minor variations in titration results.

Low risk, FDA,
Embed this list